In-Silico Structure Database (LMISSD)
BackLMISSD: Lipid Classification search results
Fatty Acyls [FA](W) --> Docosanoids [FA04] --> Neuroprostanes [FA0401]
| LM_ID | Common Name | Systematic Name | Formula | Mass |
|---|---|---|---|---|
| LMFA04010404 | ent-10-epi-7-A4-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1R,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010405 | 7,10-diepi-7-A4-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010406 | ent-7-A4-NeuroP | (R,4Z,8E)-7-hydroxy-9-((1S,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010407 | 7-A4-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010408 | ent-7,10-diepi-7-A4-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1R,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010409 | 10-epi-7-A4-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2R)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010410 | ent-7-epi-7-A4-NeuroP | (S,4Z,8E)-7-hydroxy-9-((1S,2S)-2-((2Z,5Z)-octa-2,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,8-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010411 | 10-epi-10-A4-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010412 | ent-13-epi-10-A4-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1R,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010413 | 10,13-diepi-10-A4-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010414 | ent-10-A4-NeuroP | (R,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010415 | 10-A4-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010416 | ent-10,13-diepi-10-A4-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1R,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010417 | 13-epi-10-A4-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010418 | ent-10-epi-10-A4-NeuroP | (S,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010419 | 11-epi-11-A4-NeuroP | 3-((1R,2R)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010420 | ent-4-epi-11-A4-NeuroP | 3-((1R,2S)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010421 | 4,11-diepi-11-A4-NeuroP | 3-((1S,2R)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010422 | ent-11-A4-NeuroP | 3-((1S,2S)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010423 | 11-A4-NeuroP | 3-((1R,2R)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010424 | ent-4,11-diepi-11-A4-NeuroP | 3-((1R,2S)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010425 | 4-epi-11-A4-NeuroP | 3-((1S,2R)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010426 | ent-11-epi-11-A4-NeuroP | 3-((1S,2S)-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid | C22H30O4 | 358.2144 |
| LMFA04010427 | 13-epi-13-A4-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010428 | ent-16-epi-13-A4-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010429 | 13,16-diepi-13-A4-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010430 | ent-13-A4-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010431 | 13-A4-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010432 | ent-13,16-diepi-13-A4-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010433 | 16-epi-13-A4-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010434 | ent-13-epi-13-A4-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H30O4 | 358.2144 |
| LMFA04010435 | 14-epi-14-A4-NeuroP | (Z)-6-((1R,2R)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010436 | ent-7-epi-14-A4-NeuroP | (Z)-6-((1R,2S)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010437 | 7,14-diepi-14-A4-NeuroP | (Z)-6-((1S,2R)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010438 | ent-14-A4-NeuroP | (Z)-6-((1S,2S)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010439 | 14-A4-NeuroP | (Z)-6-((1R,2R)-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010440 | ent-7,14-diepi-14-A4-NeuroP | (Z)-6-((1R,2S)-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010441 | 7-epi-14-A4-NeuroP | (Z)-6-((1S,2R)-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010442 | ent-14-epi-14-A4-NeuroP | (Z)-6-((1S,2S)-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid | C22H30O4 | 358.2144 |
| LMFA04010443 | 17-epi-17-A4-NeuroP | (4Z,7Z)-9-((1R,2R)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010444 | ent-10-epi-17-A4-NeuroP | (4Z,7Z)-9-((1R,2S)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010445 | 10,17-diepi-17-A4-NeuroP | (4Z,7Z)-9-((1S,2R)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010446 | ent-17-A4-NeuroP | (4Z,7Z)-9-((1S,2S)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010447 | 17-A4-NeuroP | (4Z,7Z)-9-((1R,2R)-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010448 | ent-10,17-diepi-17-A4-NeuroP | (4Z,7Z)-9-((1R,2S)-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010449 | 10-epi-17-A4-NeuroP | (4Z,7Z)-9-((1S,2R)-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010450 | ent-17-epi-17-A4-NeuroP | (4Z,7Z)-9-((1S,2S)-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid | C22H30O4 | 358.2144 |
| LMFA04010451 | 20-epi-20-A4-NeuroP | (4Z,7Z,10Z)-12-((1R,2R)-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010452 | ent-13-epi-20-A4-NeuroP | (4Z,7Z,10Z)-12-((1R,2S)-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |
| LMFA04010453 | 13,20-diepi-20-A4-NeuroP | (4Z,7Z,10Z)-12-((1S,2R)-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid | C22H30O4 | 358.2144 |